Ventyx biosciences to participate in the jefferies london healthcare conference

San diego, nov. 10, 2023 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that company executives will participate in the upcoming jefferies london healthcare conference.
VTYX Ratings Summary
VTYX Quant Ranking